Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality

Author:

Maiti Abhishek12ORCID,Qiao Wei3,Sasaki Koji1ORCID,Ravandi Farhad1,Kadia Tapan M.1ORCID,Jabbour Elias J.1ORCID,Daver Naval G.1ORCID,Borthakur Gautam1ORCID,Garcia‐Manero Guillermo1ORCID,Pierce Sherry A.1,Montalbano Kathryn S.1,Pemmaraju Naveen1ORCID,Naqvi Kiran1,Ohanian Maro1ORCID,Short Nicholas J.1ORCID,Alvarado Yesid1,Takahashi Koichi1,Yilmaz Musa1ORCID,Jain Nitin1,Kornblau Steven M.1,Andreeff Michael1ORCID,Bose Prithviraj1ORCID,Ferrajoli Alessandra1,Issa Ghayas C.1,Masarova Lucia1,Thompson Philip A.1,Rausch Caitlin R.4ORCID,Ning Jing4,Kantarjian Hagop M.1ORCID,DiNardo Courtney D.1ORCID,Konopleva Marina Y.1ORCID

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas USA

3. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas USA

4. Division of Pharmacy The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

National Institutes of Health

The National Cancer Institute

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3